A study that was released through Oncotarget concluded that electronic cigarettes also damage the gum and teeth just like the other cigarettes.
The journal was published by Oncotarget, and it revealed that the gums of an e-cigarette smoker suffer similar consequences to a regular cigarette smokers’.
The team of researchers discovered that those vapors that come from the e-cigarettes release proteins that are inflammatory and cause stress within the cells. The stress imposed to the gums can eventually damage them hence causing different oral diseases to the user. How the gums are damaged depends on how often someone smokes the e-cigarettes on scimagojr.com.
Another discovery was that there are flavoring that are used in the e-cigarettes and they can also cause harm to the cells of the mouth. Fawad Javed, who is a co-author, noted that e-cigarettes contain substances such as nicotine, which is known to be harmful and causes gum diseases on LinkedIn.com.
There was also another study conducted by a team of researchers from the University Laval in Canada which showed that the cells of the mouth when exposed to the vapors from the e-cigarette die within days after they have been exposed. The team used gingival epithelial cells from the tissues of the gum and exposed them to the e-cigarette vapor.
However, Dr. Mahmoud Rouabhia, who led the study, warned that once the defensive barrier of the mouth has been damaged, then there is increased the risk of inflammation and infection of the gum disease too. It seems there are chances that one can suffer from cancer after prolonged usage and the researchers are working to establish that at https://www.dovepress.com/oncotargets-and-therapy-journal.
Oncotarget is an international peer-reviewed journal which focuses on the pathological basis of all cancer diseases, therapy potential target and protocols of treatment which are followed by improvement of patients who have cancer. Other things that the journal focuses on are the impact of the programs of cancer management and emerging therapeutic agents and protocols on the perspective of the patients such as quality life, satisfaction, and adherence.
The journal exposes new and existing therapies that are evident regarding the improvement of outcomes and also seeks to define their usage concerning uptake and acceptance by the cancer patient and those providing health care.